Brown Capital Management Lifted Gw Pharmaceuticals Plc (GWPH) Position; Sandridge Permian Trust Has 1 Sentiment

April 19, 2018 - By Linda Rogers

Brown Capital Management Llc increased Gw Pharmaceuticals Plc (GWPH) stake by 10.4% reported in 2017Q4 SEC filing. Brown Capital Management Llc acquired 3,511 shares as Gw Pharmaceuticals Plc (GWPH)’s stock declined 18.69%. The Brown Capital Management Llc holds 37,280 shares with $4.92 million value, up from 33,769 last quarter. Gw Pharmaceuticals Plc now has $3.76 billion valuation. The stock decreased 0.55% or $0.74 during the last trading session, reaching $133.39. About 335,488 shares traded. GW Pharmaceuticals plc (NASDAQ:GWPH) has declined 9.18% since April 19, 2017 and is downtrending. It has underperformed by 20.73% the S&P500.

Sandridge Permian Trust (PER) investors sentiment increased to 1 in 2017 Q4. It’s up 0.36, from 0.64 in 2017Q3. The ratio improved, as 11 investment managers increased and started new equity positions, while 11 reduced and sold their stakes in Sandridge Permian Trust. The investment managers in our database now hold: 2.92 million shares, up from 1.95 million shares in 2017Q3. Also, the number of investment managers holding Sandridge Permian Trust in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 3 Reduced: 8 Increased: 3 New Position: 8.

Among 13 analysts covering GW Pharmaceuticals (NASDAQ:GWPH), 11 have Buy rating, 1 Sell and 1 Hold. Therefore 85% are positive. GW Pharmaceuticals had 28 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Leerink Swann given on Monday, October 2. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Overweight” rating by Morgan Stanley on Thursday, August 13. The firm earned “Buy” rating on Monday, March 14 by Roth Capital. The stock of GW Pharmaceuticals plc (NASDAQ:GWPH) earned “Buy” rating by Evercore on Wednesday, August 16. The firm has “Hold” rating by Numis Securities given on Friday, August 26. Cantor Fitzgerald maintained it with “Buy” rating and $192.0 target in Monday, February 5 report. Cantor Fitzgerald initiated it with “Buy” rating and $181 target in Friday, June 3 report. The firm has “Buy” rating given on Thursday, August 3 by Piper Jaffray. The rating was maintained by Cowen & Co with “Buy” on Monday, September 25. Janney Capital initiated GW Pharmaceuticals plc (NASDAQ:GWPH) on Monday, June 27 with “Sell” rating.

Brown Capital Management Llc decreased Nuance Communications Inc (NASDAQ:NUAN) stake by 45,187 shares to 441,455 valued at $7.22M in 2017Q4. It also reduced American Software Inc (NASDAQ:AMSWA) stake by 28,495 shares and now owns 4.19 million shares. Guidewire Software Inc (NYSE:GWRE) was reduced too.

SandRidge Permian Trust holds royalty interests in specified oil and natural gas properties in the Permian Basin located in Andrews County, Texas. The company has market cap of $105.00 million. It has proved developed reserves of approximately 0.3 million barrels of oil equivalent. It has a 4.31 P/E ratio.

Virtu Financial Llc holds 0.02% of its portfolio in SandRidge Permian Trust for 151,279 shares. Putnam Investments Llc owns 97,312 shares or 0.01% of their US portfolio. Moreover, American Research & Management Co. has 0% invested in the company for 200 shares. The Georgia-based Atlantic Trust Group Llc has invested 0% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 6,026 shares.

SandRidge Permian Trust (NYSE:PER) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>